“Finding the needle in a haystack”: oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP)

[1]  P. Mozer,et al.  Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer? , 2016, The Journal of urology.

[2]  P. Mozer,et al.  detection of prostate cancer in patients with a single suspicious focus on multiparametric prostate MRI ? Results of a multicentric controlled trial , 2016 .

[3]  M. Elhilali,et al.  Incidental Prostate Cancer Diagnosis During Holmium Laser Enucleation: Assessment of Predictors, Survival, and Disease Progression. , 2015, Urology.

[4]  M. Oelke,et al.  EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. , 2015, European urology.

[5]  D. Tzou,et al.  HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century. , 2015, American journal of clinical and experimental urology.

[6]  BhojaniNaeem,et al.  Coexisting Prostate Cancer Found at the Time of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia: Predicting Its Presence and Grade in Analyzed Tissue , 2015 .

[7]  H. Sakamoto,et al.  Preoperative parameters to predict incidental (T1a and T1b) prostate cancer. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[8]  Seung-June Oh,et al.  Prostate cancer detected after Holmium laser enucleation of prostate (HoLEP): significance of transrectal ultrasonography , 2014, International Urology and Nephrology.

[9]  I. Frank,et al.  Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: an outcomes analysis. , 2014, Journal of endourology.

[10]  S. Kaplan,et al.  Incidental Prostate Cancer in Transurethral Resection of the Prostate Specimens in the Modern Era , 2014, Advances in urology.

[11]  C. Gratzke,et al.  Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) , 2019 .

[12]  Danfeng Xu,et al.  Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. , 2013, Journal of endourology.

[13]  J. Lingeman,et al.  Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. , 2013, The Journal of urology.

[14]  Thomas Wiegel,et al.  Guidelines on Prostate Cancer , 2013 .

[15]  Peter J. Gilling,et al.  In 2013, Holmium Laser Enucleation of the Prostate (HoLEP) May Be the New ‘Gold Standard’ , 2012, Current Urology Reports.

[16]  M. Elhilali,et al.  Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. , 2012, The Journal of urology.

[17]  A. Westenberg,et al.  Long‐term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years , 2012, BJU international.

[18]  M. Elhilali,et al.  Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. , 2011, The Journal of urology.

[19]  M. Wirth,et al.  Risk factors for incidental prostate cancer—who should not undergo vaporization of the prostate for benign prostate hyperplasia? , 2011, The Prostate.

[20]  M. Humphreys,et al.  Incidental prostate cancer revisited: Early outcomes after holmium laser enucleation of the prostate , 2011, International journal of urology : official journal of the Japanese Urological Association.

[21]  J. Lingeman,et al.  Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. , 2010, The Journal of urology.

[22]  B. Helfand,et al.  Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. , 2009, Urology.

[23]  B. Hadaschik,et al.  Outcome of radical prostatectomy for incidental carcinoma of the prostate , 2009, BJU international.

[24]  J. Jones,et al.  Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA era , 2009, Prostate Cancer and Prostatic Diseases.

[25]  A. Grant,et al.  Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials , 2008, BMJ : British Medical Journal.

[26]  S. Ahyai,et al.  Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. , 2008, European urology.

[27]  A. Tan,et al.  Meta‐analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction , 2007, The British journal of surgery.

[28]  L. Ferrucci,et al.  Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. , 2006, Journal of the National Cancer Institute.

[29]  S. Loening,et al.  The ratio of prostate‐specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL , 2005, Cancer.

[30]  M. Lykourinas,et al.  Characteristics of patients with stage T1b incidental prostate cancer , 2005, Scandinavian journal of urology and nephrology.

[31]  F. Montorsi,et al.  Holmium laser enucleation versus transurethral resection of the prostate. Are histological findings comparable? , 2003, The Journal of urology.

[32]  M. Benson,et al.  An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density , 2004, World Journal of Urology.

[33]  R. Tooher.  A systematic review of holmium laser prostatectomy , 2003 .

[34]  Klaus Jung,et al.  Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. , 2002, Clinical chemistry.

[35]  S. Ciatto,et al.  Predicting Prostate Biopsy Outcome by Findings at Digital Rectal Examination, Transrectal Ultrasonography, PSA, PSA Density and Free-To-Total PSA Ratio in a Population-Based Screening Setting , 2001, The International journal of biological markers.

[36]  H. Yamanaka,et al.  Determination of reference values for total PSA, F/T and PSAD according to prostatic volume in japanese prostate cancer patients with slightly elevated serum PSA levels. , 1999, Japanese journal of clinical oncology.